HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells

References

• DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014; 64:52-62; PMID:24114568
   PubMed Web of Science ®Google Scholar
• Whelan J. First clinical data on RNAi. Drug Discov Today 2005; 10:1014-5; PMID:16055013; http://dx.doi.org/10.1016/S1359-6446(05)03547-6
   PubMed Web of Science ®Google Scholar
• Fire A. Gene silencing by double-stranded RNA. Cell Death Differ 2007; 14:1998-2012; PMID:18007671; http://dx.doi.org/10.1038/sj.cdd.4402253
   PubMed Web of Science ®Google Scholar
• Kachalaki S, Baradaran B, Majidi J, Yousefi M, Shanehbandi D, Mohammadinejad S, Mansoori B. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60). Biomed Pharmacother 2015; 75:100-4; PMID:26463638; http://dx.doi.org/10.1016/j.biopha.2015.08.032
   PubMed Web of Science ®Google Scholar
• Montazami N, Kheirandish M, Majidi J, Yousefi M, Yousefi B, Mohamadnejad L, Shanebandi D, Estiar M, Khaze V, Mansoori B. siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells. Cell Mol Biol (Noisy-le-Grand, France) 2015; 61:98; PMID:26025411
   PubMed Web of Science ®Google Scholar
• Mansoori B, Shotorbani SS, Baradaran B. RNA Interference and its Role in Cancer Therapy. 2014.
   Google Scholar
• Mansoori B, Mohammadi A, Shir Jang S, Baradaran B. Mechanisms of immune system activation in mammalians by small interfering RNA (siRNA). Artif Cells Nanomed Biotechnol 2015:1-8; PMID:26497011; http://dx.doi.org/10.3109/21691401.2015.1102738
   PubMed Web of Science ®Google Scholar
• Narita M, Narita M, Krizhanovsky V, Nuñez S, Chicas A, Hearn SA, Myers MP, Lowe SW. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006; 126:503-14; PMID:16901784; http://dx.doi.org/10.1016/j.cell.2006.05.052
   PubMed Web of Science ®Google Scholar
• Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 2001; 277:63-81; PMID:11602345; http://dx.doi.org/10.1016/S0378-1119(01)00689-8
   PubMed Web of Science ®Google Scholar
• Natarajan S, Hombach-Klonisch S, Dröge P, Klonisch T. HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells. Neoplasia 2013; 15:263-IN13; PMID:23479505; http://dx.doi.org/10.1593/neo.121988
   PubMed Web of Science ®Google Scholar
• Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 1996; 13:2439-46; PMID:8957086
   PubMed Web of Science ®Google Scholar
• Hirning‐Folz U, Wilda M, Rippe V, Bullerdiek J, Hameister H. The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer 1998; 23:350-7; http://dx.doi.org/10.1002/(SICI)1098-2264(199812)23:4%3c350::AID-GCC10%3e3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Gattas GJ, Quade BJ, Nowak RA, Morton CC. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 1999; 25:316-22; http://dx.doi.org/10.1002/(SICI)1098-2264(199908)25:4%3c316::AID-GCC2%3e3.0.CO;2-0
   PubMed Web of Science ®Google Scholar
• Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, Bullerdiek J. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 1996; 149:775; PMID:8780382
   PubMed Web of Science ®Google Scholar
• Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, Vollmer E, Bullerdiek J. HMGA2 overexpression in non-small cell lung cancer. Mol Carcinog 2007; 46:503-11; PMID:17477356; http://dx.doi.org/10.1002/mc.20235
   PubMed Web of Science ®Google Scholar
• Abe N, Watanabe T, Suzuki Y, Matsumoto N, Masaki T, Mori T, Sugiyama M, Chiappetta G, Fusco A, Atomi Y. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer 2003; 89:2104-9; PMID:14647145; http://dx.doi.org/10.1038/sj.bjc.6601391
   PubMed Web of Science ®Google Scholar
• Malek A, Bakhidze E, Noske A, Sers C, Aigner A, Schäfer R, Tchernitsa O. HMGA2 gene is a promising target for ovarian cancer silencing therapy. Int J Cancer 2008; 123:348-56; PMID:18452175; http://dx.doi.org/10.1002/ijc.23491
   PubMed Web of Science ®Google Scholar
• Guang-meng X, Hai-na Z, Xiao-feng T, Mei S, Xue-dong F. Effect of HMGA2 shRNA on the Cell Proliferation and Invasion of Human Colorectal Cancer SW480 Cells< em>In vitro. Chem Res Chinese Universites 2012; 28:264-8.
   Web of Science ®Google Scholar
• Chau K-Y, Manfioletti G, Cheung-Chau K-W, Fusco A, Dhomen N, Sowden JC, Sasabe T, Mukai S, Ono SJ. Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation. Mol Med 2003; 9:154; PMID:14571323; http://dx.doi.org/10.2119/2003-00020.Ono
   PubMed Web of Science ®Google Scholar
• Miyazawa J, Mitoro A, Kawashiri S, Chada KK, Imai K. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 2004; 64:2024-9; PMID:15026339; http://dx.doi.org/10.1158/0008-5472.CAN-03-1855
   PubMed Web of Science ®Google Scholar
• Andrieux J, Demory JL, Dupriez B, Quief S, Plantier I, Roumier C, Bauters F, Laï JL, Kerckaert JP. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 2004; 39:82-7; http://dx.doi.org/10.1002/gcc.10297
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21:1025-30; PMID:17437991; http://dx.doi.org/10.1101/gad.1540407
   PubMed Web of Science ®Google Scholar
• Thuault S, Tan E-J, Peinado H, Cano A, Heldin C-H, Moustakas A. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 2008; 283:33437-46; PMID:18832382; http://dx.doi.org/10.1074/jbc.M802016200
   PubMed Web of Science ®Google Scholar
• Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 2007; 6:5; PMID:17222355; http://dx.doi.org/10.1186/1476-4598-6-5
   PubMed Web of Science ®Google Scholar
• Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315:1576-9; PMID:17322030; http://dx.doi.org/10.1126/science.1137999
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Shirjang S, Baradaran B. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Cell Mol Biol (Noisy-le-Grand, France) 2014; 61:1-10.
   Web of Science ®Google Scholar
• Ma Z-L, Hou P-P, Li Y-L, Wang D-T, Yuan T-W, Wei J-L, Zhao B-T, Lou J-T, Zhao X-T, Jin Y. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2. Tumor Biol 2015; 36:2481-90; PMID:25501507; http://dx.doi.org/10.1007/s13277-014-2861-5
   PubMed Web of Science ®Google Scholar
• Li L, Wu J, Sima X, Bai P, Deng W, Deng X, Zhang L, Gao L. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumor Biol 2013; 34:1919-23; PMID:23504554; http://dx.doi.org/10.1007/s13277-013-0736-9
   PubMed Web of Science ®Google Scholar
• Cao W, Fan R, Wang L, Cheng S, Li H, Jiang J, Geng M, Jin Y, Wu Y. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. Tumor Biol 2013; 34:963-71; PMID:23264087; http://dx.doi.org/10.1007/s13277-012-0632-8
   PubMed Web of Science ®Google Scholar
• Karami H, Baradaran B, Esfahani A, Sakhinia M, Sakhinia E. Therapeutic Effects of Myeloid Cell Leukemia-1 siRNA on Human Acute Myeloid Leukemia Cells. Adv Pharm Bull 2014; 4:243; PMID:24754007
   PubMedGoogle Scholar
• Zaffaroni N, Daidone MG. Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions. Drug Resist Updat 2002; 5:65-72; PMID:12135582; http://dx.doi.org/10.1016/S1368-7646(02)00049-3
   PubMed Web of Science ®Google Scholar
• Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 2006; 12:11-9; PMID:16397018; http://dx.doi.org/10.1158/1078-0432.CCR-04-1752
   PubMed Web of Science ®Google Scholar
• HOECKER P, FISCHER MB, JAKESZ R, ZEILLINGER R. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer. Oncol Rep 2005; 14:737-41; PMID:16077985
   PubMed Web of Science ®Google Scholar
• Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 2008; 14:2334-40; PMID:18413822; http://dx.doi.org/10.1158/1078-0432.CCR-07-4667
   PubMed Web of Science ®Google Scholar
• Sarhadi V, Wikman H, Salmenkivi K, Kuosma E, Sioris T, Salo J, Karjalainen A, Knuutila S, Anttila S. Increased expression of high mobility group A proteins in lung cancer. J Pathol 2006; 209:206-12; PMID:16521118; http://dx.doi.org/10.1002/path.1960
   PubMed Web of Science ®Google Scholar
• Wang Q, Gong Y, Lü Y, Fei L, Liu H, Diao Y, Xu R. [Selection and anti-cancer effects of siRNAs targeting HMGA2 gene]. Yao Xue Xue Bao 2011; 46:1444-50; PMID:22375416
   PubMedGoogle Scholar
• Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1, and p53: the feedback loop. Cell Cycle 2009; 8:712-5; PMID:19221490; http://dx.doi.org/10.4161/cc.8.5.7753
   PubMed Web of Science ®Google Scholar
• Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17:193-9; PMID:19461653; http://dx.doi.org/10.1038/cdd.2009.56
   PubMed Web of Science ®Google Scholar
• Heldin C-H, Landström M, Moustakas A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009; 21:166-76; PMID:19237272; http://dx.doi.org/10.1016/j.ceb.2009.01.021
   PubMed Web of Science ®Google Scholar
• Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2009; 17:193-9; PMID:19461653; http://dx.doi.org/10.1038/cdd.2009.56
   PubMed Web of Science ®Google Scholar
• Song J, Bai Z, Han W, Zhang J, Meng H, Bi J, Ma X, Han S, Zhang Z. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 2012; 57:897-904; PMID:22198701; http://dx.doi.org/10.1007/s10620-011-1981-7
   PubMed Web of Science ®Google Scholar